Eagle Pharmaceuticals Investor Relations Material
Latest events
Q2 2023
Eagle Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Eagle Pharmaceuticals Inc
Access all reports
Eagle Pharmaceuticals Inc develops and commercializes injectable and specialty pharmaceutical products. The company focuses on reformulating and improving existing therapies in oncology, critical care, and central nervous system disorders. It serves healthcare providers and hospitals in the United States. The company is headquartered in Woodcliff Lake, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
EGRX
Country
🇺🇸 United States